No internet connection — showing the saved version of the page.

Charles River Lab…

USUSD
← to the screener

Charles River Laboratories International, Inc. (US:CRL) — Biotechnology: Commercial Physical & Biological Resarch. Number of exchanges where the company shares trade: 1. On this page — price and chart, dividends, top holders and share count history.

About the company

Website
criver.com
Sector
Health Care · Biotechnology: Commercial Physical & Biological Resarch
Headquarters
Wilmington
Founded
1947
IPO
2000-06-23
Shares outstanding
47.92 M as of 2026-10-24
Year: −3.0% · 3 years: −6.9% · 5 years: −5.4% (excluding splits)
DateSharesChange
25.07.202647.74 M−0.9%buyback
24.04.202648.17 M−2.2%buyback
24.01.202649.23 M+0.03%no significant change
25.10.202549.22 M—no significant change
26.07.202549.21 M+0.2%issuance (dilution)
26.04.202549.12 M−4.0%buyback
25.01.202551.14 M+0.01%no significant change
26.10.202451.14 M−1.0%buyback
27.07.202451.63 M+0.2%issuance (dilution)
27.04.202451.51 M+0.3%issuance (dilution)
27.01.202451.35 M+0.1%issuance (dilution)
27.10.202351.3 M+0.05%no significant change
28.07.202351.27 M+0.2%issuance (dilution)
28.04.202351.18 M+0.4%issuance (dilution)
25.01.202350.99 M+0.2%issuance (dilution)
Share count from the company reports. A split is detected by a jump in the count by a whole number of times.
Market cap
17.95 B USD
Industry (SIC)
Services-Commercial Physical & Biological Research
Legal form
XTIQ
Parent company
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
ISIN
US1598641074
LEI
5493008S8WYPIT0LWO97
P/E
357
EPS
0.92 USD
|
4.87
ROE
1.3%
FCF
400 M USD
Debt
2.45 B USD
5.6 y of FCF
Earnings and FCF — for the 12 months to 26.09.2026 (the company's latest report).
Net income
40.2 M USD 12 mo.
For the 12 months to 26.09.2026 (4 quarters)
Revenue3.98 B USD
− Expenses3.82 B USD
Net income40.2 M USD
History by quarter
RevenueExpensesLoss
30.12.2023: Revenue 1.01 B · Expenses 881 M · Operating profit 133 M · Net income 187 M30.03.2024: Revenue 1.01 B · Expenses 886 M · Operating profit 126 M · Net income 73.0 M29.06.2024: Revenue 1.03 B · Expenses 874 M · Operating profit 152 M · Net income 94.1 M28.09.2024: Revenue 1.01 B · Expenses 892 M · Operating profit 117 M · Net income 69.7 M28.12.2024: Revenue 1.00 B · Expenses 1.17 B · Operating profit −168 M · Net income −214 M29.03.2025: Revenue 984 M · Expenses 909 M · Operating profit 74.7 M · Net income 25.5 M28.06.2025: Revenue 1.03 B · Expenses 932 M · Operating profit 100 M · Net income 52.3 M27.09.2025: Revenue 1.00 B · Expenses 871 M · Operating profit 134 M · Net income 54.4 M27.12.2025: Revenue 994 M · Expenses 1.28 B · Operating profit −283 M · Net income −277 M28.03.2026: Revenue 996 M · Expenses 876 M · Operating profit 120 M · Net income −14.8 M27.06.2026: Revenue 1.00 B · Expenses 884 M · Operating profit 120 M · Net income −1.48 M26.09.2026: Revenue 983 M · Expenses 780 M · Operating profit 203 M · Net income 333 M
12.202309.2026
Green above orange is profit (revenue − expenses); red below zero is a loss.
NAV
67.40 USD · P/NAV 4.87
Balance sheet date26.09.2026
Assets7.45 B USD
− Liabilities4.18 B USD
= Total equity3.23 B USD
− Non-controlling interests5.08 M USD
= NAV (equity of the company's shareholders)3.23 B USD
− Goodwill3.08 B USD
− Intangible assets239 M USD
= Tangible NAV−95.8 M USD
Shares47 876 000
NAV per share67.40 USD
Tangible NAV per share−2.00 USD
Share price (CRL)328.14 USD
P/NAV4.87
NAV history
Balance sheet dateNAVNAV per share
26.09.20263.23 B USD67.40 USD
27.06.20262.84 B USD59.50 USD
28.03.20262.94 B USD61.05 USD
27.12.20253.16 B USD64.30 USD
27.09.20253.41 B USD69.20 USD
28.06.20253.35 B USD68.14 USD
29.03.20253.19 B USD65.04 USD
28.12.20243.46 B USD67.69 USD
Description

Charles River Laboratories International, Incorporated is an American life sciences company and contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides goods and services that support the development of drugs, vaccines, and other therapeutics. — Wikipedia

advertisement

Exchanges and tickers

ExchangeTickerCurrencyPriceType
US USA StocksCRLUSD328.14 -1.53%common stock

Price

US:CRL · USD
Hover / tap a day — open, close, high and low prices

Top holders

HolderStakeSharesReport date
CHARLES RIVER LABORATORI…———